Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James C Byrd

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The American Journal of the Medical Sciences|August 18, 2004
Literacy and numeracy skills and anticoagulation controlCarlos A Estrada, Mary Martin-Hryniewicz, Brian T Peek, et al.
Archives of Biochemistry and Biophysics|December 18, 2003
Alternative splicing of the human MUC2 geneLawrence R Sternberg, James C Byrd, Gunnar C Hansson, et al.
Gastroenterology|August 29, 2002
Expression of human intestinal mucin is modulated by the beta-galactoside binding protein galectin-3 in colon cancerSteven P Dudas, Christopher K Yunker, Lawrence R Sternberg, et al.
Cancer|September 20, 2013
Induction of MUC5AC mucin by conjugated bile acids in the esophagus involves the phosphatidylinositol 3-kinase/protein kinase C/activator protein-1 pathwayShumei Song, James C Byrd, Sushovan Guha, et al.
Gastroenterology|November 16, 2005
Galectin-3 modulates MUC2 mucin expression in human colon cancer cells at the level of transcription via AP-1 activationShumei Song, James C Byrd, Nachman Mazurek, et al.
Endocrinology|February 15, 2003
Opposing roles for the insulin-like growth factor (IGF)-II and mannose 6-phosphate (Man-6-P) binding activities of the IGF-II/Man-6-P receptor in the growth of prostate cancer cellsBeverly S Schaffer, Ming-Fong Lin, James C Byrd, et al.
BMC Clinical Pathology|January 18, 2006
Inclusion of MUC1 (Ma695) in a panel of immunohistochemical markers is useful for distinguishing between endocervical and endometrial mucinous adenocarcinomaThaer Khoury, Dongfeng Tan, Jianmin Wang, et al.
Cell Death & Disease|August 12, 2016
Cell surface galectin-3 defines a subset of chemoresistant gastrointestinal tumor-initiating cancer cells with heightened stem cell characteristicsMatthias Ilmer, Nachman Mazurek, James C Byrd, et al.
The Journal of Biological Chemistry|April 1, 2003
Binding of urokinase-type plasminogen activator receptor (uPAR) to the mannose 6-phosphate/insulin-like growth factor II receptor: contrasting interactions of full-length and soluble forms of uPARJodi L Kreiling, James C Byrd, Robert J Deisz, et al.
Cancer|December 15, 2005
Calcium plus vitamin D alters preneoplastic features of colorectal adenomas and rectal mucosaPeter R Holt, Robert S Bresalier, Chan K Ma, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The American Journal of the Medical Sciences|August 18, 2004
Literacy and numeracy skills and anticoagulation controlCarlos A Estrada, Mary Martin-Hryniewicz, Brian T Peek, et al.
Archives of Biochemistry and Biophysics|December 18, 2003
Alternative splicing of the human MUC2 geneLawrence R Sternberg, James C Byrd, Gunnar C Hansson, et al.
Gastroenterology|August 29, 2002
Expression of human intestinal mucin is modulated by the beta-galactoside binding protein galectin-3 in colon cancerSteven P Dudas, Christopher K Yunker, Lawrence R Sternberg, et al.
Cancer|September 20, 2013
Induction of MUC5AC mucin by conjugated bile acids in the esophagus involves the phosphatidylinositol 3-kinase/protein kinase C/activator protein-1 pathwayShumei Song, James C Byrd, Sushovan Guha, et al.
Gastroenterology|November 16, 2005
Galectin-3 modulates MUC2 mucin expression in human colon cancer cells at the level of transcription via AP-1 activationShumei Song, James C Byrd, Nachman Mazurek, et al.
Endocrinology|February 15, 2003
Opposing roles for the insulin-like growth factor (IGF)-II and mannose 6-phosphate (Man-6-P) binding activities of the IGF-II/Man-6-P receptor in the growth of prostate cancer cellsBeverly S Schaffer, Ming-Fong Lin, James C Byrd, et al.
BMC Clinical Pathology|January 18, 2006
Inclusion of MUC1 (Ma695) in a panel of immunohistochemical markers is useful for distinguishing between endocervical and endometrial mucinous adenocarcinomaThaer Khoury, Dongfeng Tan, Jianmin Wang, et al.
Cell Death & Disease|August 12, 2016
Cell surface galectin-3 defines a subset of chemoresistant gastrointestinal tumor-initiating cancer cells with heightened stem cell characteristicsMatthias Ilmer, Nachman Mazurek, James C Byrd, et al.
The Journal of Biological Chemistry|April 1, 2003
Binding of urokinase-type plasminogen activator receptor (uPAR) to the mannose 6-phosphate/insulin-like growth factor II receptor: contrasting interactions of full-length and soluble forms of uPARJodi L Kreiling, James C Byrd, Robert J Deisz, et al.
Cancer|December 15, 2005
Calcium plus vitamin D alters preneoplastic features of colorectal adenomas and rectal mucosaPeter R Holt, Robert S Bresalier, Chan K Ma, et al.
Pageof 3